Contact this trialFirst, we need to learn more about you.
Alkylating agents
Reduced Radio-Chemotherapy for Oral Cancer
Recruiting1 awardPhase 2
Jacksonville, Florida
This trial found that risk-adapted de-intensification of radiation therapy and chemotherapy based on HPV subtype, plasma circulating free HPV DNA (cfHPV DNA) level, and cfHPV DNA clearance rate is just as effective as more aggressive therapy in patients with favorable prognosis oropharyngeal squamous cell carcinoma (OPSCC).
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service